Replies to post #158566 on Anavex Life Sciences Corp (AVXL)

[Gernee20]

Tempephil- all I’m saying is it will not serve them benefit not to PR. I don’t care when they PR, just PR the info they are presenting. The genetic biiomarkers found by Anavex -which influence 2-73 efficacy is a big deal, and needs to be released as “news” because all our future trials success/failure seems to be hinging on these findings. And, not to mention will educate new investors and should attract some new buyers.